A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy.
暂无分享,去创建一个
Xin Hu | Zicheng Xu | Xiao Li | Feng Qi | Yuxiao Zheng | H. Cai | Ting Xu | Bin Yu | Q. Zou
暂无分享,去创建一个
Xin Hu | Zicheng Xu | Xiao Li | Feng Qi | Yuxiao Zheng | H. Cai | Ting Xu | Bin Yu | Q. Zou